Aspiriant LLC
MNST icon

Aspiriant LLC’s Monster Beverage MNST Stock Holding History

Aspiriant LLC’s Portfolio MNST Stock Details MNST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		– Sell
-4,180
Closed -$201K – 446
2026
Q2 		$201K Buy
+4,180
New +$176K 0.01% 388
2025
Q3 		– Sell
-9,298
Closed -$291K – 307
2025
Q2 		$291K Buy
+9,298
New +$284K 0.01% 260

Other funds holding MNST

Ninety One (UK)
Ninety One (UK) London, United Kingdom $45.5B AUM 15.2% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
Montrusco Bolton Investments
Montrusco Bolton Investments Montreal, Quebec, Canada $5.77B AUM 24.61% 1-Year Est. Return
Cardinal Capital Management Inc (Canada)
Cardinal Capital Management Inc (Canada) Winnipeg, Manitoba, Canada $4.41B AUM 21.96% 1-Year Est. Return
Fort Washington Investment Advisors
Fort Washington Investment Advisors Cincinnati, Ohio $19.7B AUM 20.11% 1-Year Est. Return
Fjarde Ap-fonden
Fjarde Ap-fonden Stockholm, Sweden $19.4B AUM 31.69% 1-Year Est. Return
ABN AMRO Investment Solutions
ABN AMRO Investment Solutions Paris Cedex 008 $13.2B AUM 30.55% 1-Year Est. Return
Ninety One North America
Ninety One North America New York $2.13B AUM 8.8% 1-Year Est. Return
AssetMark Inc
AssetMark Inc Concord, California $59.5B AUM 15.92% 1-Year Est. Return

Aspiriant LLC's MNST Position: Q3 2026 in Review

Aspiriant LLC sold out of Monster Beverage (MNST) in Q3 2026, closing a stake of 4,180 shares — an estimated $201K sold.

Aspiriant LLC first reported a position in MNST in Q2 2025 and held it in 2 quarters. The position peaked at $291K in Q2 2025. 247 funds tracked by Wall St. Rank hold MNST as of Q3 2026.

  • Aspiriant LLC reported no remaining Monster Beverage position as of Q3 2026 after selling out during the quarter.
  • Aspiriant LLC sold 4,180 Monster Beverage shares in Q3 2026, an estimated $201K.
  • Aspiriant LLC first reported a position in Monster Beverage in Q2 2025 and held it in 2 quarters.
  • Aspiriant LLC's Monster Beverage position peaked at $291K in Q2 2025.
  • 247 funds tracked by Wall St. Rank held Monster Beverage as of Q3 2026.

Based on Aspiriant LLC's 13F filing for Q3 2026, filed 16 Oct 2026.